cyclosporine and Glomerulonephritis, Membranous

cyclosporine has been researched along with Glomerulonephritis, Membranous in 142 studies

Research

Studies (142)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	31 (21.83)	18.2507
2000's	29 (20.42)	29.6817
2010's	65 (45.77)	24.3611
2020's	17 (11.97)	2.80

Authors

Authors	Studies
Au, EH; Chen, Y; Hodson, EM; Mathew, AT; Tunnicliffe, DJ; von Groote, TC; Williams, G	1
Chen, YW; Cui, S; Lai, JJ; Li, TL; Ou, JY; Shan, HZ; Xiao, Y	1
Köllner, SMS; Seifert, L; Tomas, NM; Zahner, G	1
Harth, A; Jörres, A; Özcan, F; Tillmann, FP	1
Chen, M; Xiong, Y; Xu, G; Zhang, X	1
Bystrova, OB; Dobronravov, VA; Fomicheva, EN; Kochoyan, ZS	1
Hara, S; Nozu, K; Tanaka, Y; Yamamoto, M	1
Furuichi, K; Ishimoto, T; Koizumi, M; Kurita, N; Nakaya, I; Nishiwaki, H; Oe, Y; Okada, H; Sasaki, S; Shimizu, S; Sofue, T; Wada, T	1
Li, Y; Tan, T; Zeng, Y; Zheng, Y	1
Colucci, M; Conversano, E; Debiec, H; Emma, F; Ronco, P; Vivarelli, M	1
Appel, GB; Aslam, N; Barbour, SJ; Brenchley, PE; Cattran, DC; Fervenza, FC; Hladunewich, MA; Induruwage, D; Kiryluk, K; Lafayette, R; Liu, L; Reich, HN; Rovin, B; Zand, L	1
Akashi, T; Ashida, K; Demiya, M; Fukami, K; Ito, H; Kubo, S; Motomura, S; Nagayama, A; Nomura, M; Ueda, U	1
Chang, YK; Choi, BS; Chung, BH; Hong, YA; Hwang, HS; Kim, SY; Kim, Y; Kim, YS; Park, CW; Yang, CW; Yoon, HE	1
Griffith, M; Nikolopoulou, A	1
Austin, HA; Balow, JE; Waldman, M	1
Moroni, G; Ponticelli, C	1
Cattran, DC; Fervenza, FC	1
Beck, LH; Trivin-Avillach, C	1
Chen, Y; Dong, W; Fu, L; Li, R; Li, Z; Liang, H; Liang, X; Liu, S; Shi, W; Song, L; Tao, Y; Wang, W; Wu, Y; Xie, J; Xie, Z; Ye, Z	1
Del Vecchio, L; Locatelli, F; Patrizia, P; Ponticelli, C	1
Gong, S; Li, J; Lu, W; Luo, H; Wang, Y	1
Bokos, I; Boletis, I; Gavalas, I; Liapis, G; Lionaki, S; Makropoulos, I; Marinaki, S; Michelakis, I; Panagiotellis, K; Vlachopanos, G	1
Fujii, T; Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Kawada, M; Mizuno, H; Ohashi, K; Sawa, N; Sekine, A; Suwabe, T; Takaichi, K; Ubara, Y; Ueno, T; Yabuuchi, J; Yamanouchi, M	1
Akiyama, S; Ishimoto, T; Ito, Y; Kato, N; Katsuno, T; Kim, H; Kosugi, T; Maruyama, S; Ozaki, T; Suzuki, Y; Tsuboi, N	1
Cui, Z; Liu, G; Liu, X; Meng, L; Qu, Z; Ruan, L; Wang, F; Wang, X; Yang, L; Yu, X; Zhang, Y	1
Hong, D; Jardine, M; Li, G; Perkovic, V; Ren, S; Toyama, T; Wang, Y; Xian, L	1
An, WS; Cho, JH; Cho, KH; Choi, JY; Chung, HC; Jung, HY; Kim, CD; Kim, DK; Kim, YL; Kim, YW; Lee, DH; Lee, JP; Park, SH; Yoo, TH	1
Cai, JF; Gu, X; He, YD; Li, H; Li, XW; Luo, K; Wang, SR; Xie, HY; Xu, P; Xu, Q; Yu, ZM; Zou, PM	1
Akiyama, S; Arai, H; Endo, S; Kamimatsuse, R; Maruyama, S; Matsubara, T; Nishioka, K; Toda, N; Yanagita, M; Yokoi, H	1
Li, C; Li, H; Li, XM; Li, XW; Wen, YB	1
Hu, B; Kuang, F; Liu, D; Qing, S; Yang, Y; Yu, X	1
Ding, H; Li, Z; Zhang, J	1
Di Stasio, E; Manzione, A; Menè, P; Pirozzi, N; Stoppacciaro, A; Zotta, F	1
Appel, GB; Aslam, N; Avila-Casado, C; Barbour, SJ; Beanlands, H; Beara-Lasic, L; Blumenthal, SS; Brenchley, P; Canetta, PA; Cattran, DC; da Costa, BR; Erickson, SB; Fervenza, FC; Gipson, DS; Gipson, PE; Green, DF; Hebert, LA; Hladunewich, M; Jefferson, JA; Juncos, LA; Jüni, P; Lafayette, RA; Lee, DK; Leung, N; Li, T; Lieske, JC; McCarthy, ET; Parikh, SV; Philibert, D; Radhakrishnan, J; Reich, HN; Rizk, DV; Rovin, BH; Sedor, JR; Sethi, S; Simon, JF; Sussman, AN; Thomas, LF	1
Remuzzi, G; Ruggenenti, P	3
Li, HY; Lin, S; Lin, W; Zhou, T	1
Choi, KH; Doh, FM; Han, JH; Han, SH; Kang, SW; Kim, HR; Koo, HM; Lee, MJ; Oh, HJ; Park, JT; Shin, DH; Yoo, TH	1
Gödel, M; Huber, TB	1
Cirillo, M	1
Dhaun, N; Kluth, DC	1
Chen, Z; Du, X	1
Hofstra, J; Wetzels, J	1
Mathieson, PW	1
Ahmad, MS; Al-Brahim, N; El-Merhi, K; Zaki, AH	1
Hiramoto, N; Iwasa, T; Matsuura, T; Ohashi, K; Shoji, M	1
Imai, E; Iwano, M; Kataoka, Y; Koyama, A; Maruyama, S; Matsumoto, K; Matsuo, S; Mitarai, T; Nangaku, M; Nishi, S; Ogahara, S; Saito, T; Sato, H; Shuto, H; Tomino, Y; Ueda, S; Yokoyama, H; Yorioka, N; Yoshimura, A	1
Fujimoto, S; Makino, H; Maruyama, S; Matsuo, S; Mori, N; Narita, I; Nishio, S; Okuda, S; Saito, T; Sato, H; Sugiyama, H; Ueda, Y; Yamagata, K; Yokoyama, H; Yuzawa, Y	1
Harendza, S; Hoxha, E; Panzer, U; Pinnschmidt, H; Stahl, RA	1
Braun, N; Cai, G; Chen, X; Chen, Y; Giuliano, GA; Perna, A; Schieppati, A; Zamora, J	1
Akiyama, S; Ando, M; Ito, Y; Kato, S; Katsuno, T; Kosugi, T; Maruyama, S; Matsuo, S; Mizuno, M; Sato, W; Tsuboi, N; Yamaguchi, M; Yamamoto, R; Yasuda, Y	1
Hassan, K; Kristal, B	1
Li, MX; Xiao, FL; Yu, YW; Zhang, ZY; Zhao, HD	1
Appel, GB; Aslam, N; Barbour, SJ; Blumenthal, SS; Brenchley, P; Canetta, PA; Cattran, DC; Dillon, JJ; Eirin, A; Fervenza, FC; Gipson, DS; Gipson, PE; Green, DF; Greene, EL; Hebert, LA; Hladunewich, MA; Hogan, MC; Irazabal, MV; Jefferson, JA; Juncos, LA; Kretzler, M; Lafayette, RA; Lasic, LB; Leung, N; Lieske, JC; McCarthy, ET; Philibert, D; Radhakrishnan, J; Reich, HN; Rizk, DV; Rovin, BH; Sedor, JR; Sethi, S; Simon, J; Sussman, AN; Thomas, LF	1
Haller, H; Hiss, M; Müller-Deile, J; Schiffer, L; Schiffer, M	1
Fu, S; Li, S; Pei, H; Tian, L; Xia, W	1
Chen, L; Lafayette, RA; Li, H; Li, M; Li, X; Sun, Y; Tao, J; Wen, Y; Zhang, W	1
Bax, KC; Filler, G; Kirpalani, A; Rieder, MJ	1
Chan, CK; Chen, PM; Chen, YM; Chiang, WC; Chiu, YL; Chou, YH; Chu, TS; Lai, TS; Wu, CF; Wu, KD	1
Goumenos, DS	1
Chen, WS; Huang, DF; Wang, HP; Young, AH	1
Chiu, MC; Lai, WM; Ma, AL	1
Diomedi-Camassei, F; Emma, F; Kengne-Wafo, S; Massella, L	1
Li, J; Liu, G; Qu, Z; Zhang, YM; Zhao, MH	1
Filiopoulos, V; Georgoulias, C; Kosmadakis, G; Michail, S; Skarlas, P; Smirloglou, D	1
Henry, V; Meyer, P; Morin, D; Raynaud, P; Rivier, F; Rodière, M; Roubertie, A; Soëte, S	1
Basta-Jovanovic, G; Jovanovic, D; Marinkovic, J; Naumovic, R; Pavlovic, S; Stosovic, M	1
Goumenos, DS; Kalliakmani, P; Koutroulia, E; Sotsiou, F; Vlachojannis, JG	1
Fukuda, S; Hashiguchi, A; Hayashi, K; Hayashi, M; Itoh, H; Konishi, K; Sakamaki, Y; Wakino, S	1
McMorrow, T; O'Connell, S; Ryan, MP; Slattery, C	1
Aaltonen, S; Honkanen, E	1
Cravedi, P; Marasà, M; Remuzzi, G; Ruggenenti, P; Salerno, A; Sghirlanzoni, MC	1
Esaki, S; Gondo, A; Hayashi, A; Matsumoto, H; Miyaoka, Y; Nagaoka, Y; Nakao, T; Okada, T; Wada, T	1
Gao, RT; Li, H; Li, MX; Li, XM; Li, XW; Liu, LL; Tao, JL; Wen, YB	1
Dixon, BS; Haynes, WG; Hommos, M; Sinkey, C	1
Chang, CH; Chen, JH; Fang, YW; Tsai, MS; Yang, AH	1
Hirayama, K; Koyama, A; Suzuki, S; Usui, J; Yamagata, K	1
Chen, D; Hu, X; Li, L; Ma, Y; Mao, Z; Mei, C; Sun, L; Xie, G; Xu, C; Xu, J; Yang, L; Ye, C; Zhao, X	1
Nozue, T; Pan, Q; Sato, Y; Tsunoda, S; Wakasugi, H; Yoshimura, A	1
Gerolymos, M; Goumenos, DS; Huang, L; Johnson, TS; Kalliakmani, P; Papasotiriou, M	1
Yim, HE; Yoo, KH	1
Audard, V; Bouachi, K; Bridoux, F; Desvaux, D; Fan, Q; Gouadon, E; Guellaën, G; Lang, P; Ollero, M; Pawlak, A; Ronco, P; Rucker-Martin, C; Sahali, D; Sendeyo, K; Zhang, SY	1
Adu, D; Boulton-Jones, M; Chapman, TL; Feehally, J; Ferguson, C; Gaskin, GJ; Howman, A; Jayne, DR; Langdon, MM; Mathieson, PW; O'Donoghue, D	1
Bartosíková, L; Necas, J; Salplachta, J	1
Cattran, DC	3
Brenchley, PE; Cattran, DC; Coupes, B; Wald, R	1
Iwasawa, H; Matsumoto, H; Nagaoka, Y; Nakao, T; Okada, T; Tomaru, R; Wada, T	1
Chen, H; Hu, W; Li, L; Li, S; Liu, Z; Shen, S; Yao, X	1
Goumenos, DS; Kalliakmani, P; Sotsiou, F; Tsakas, S; Vlachojannis, JG	1
Sobarzo Toro, M; Vilches, A	1
Aguilar, P; Muñoz Díaz, AB	1
Braun, N; Giuliano, GA; Perna, A; Remuzzi, G; Schieppati, A; Zamora, J	1
Ehrich, JH; Mengel, M; Offner, G; Pape, L	1
Hertzberg, MS; Nankivell, BJ; Stevenson, WS	1
Gillin, A; Harris, D; Johnson, D; Nicholls, K; Thomas, M	1
Alexopoulos, E; Leontsini, M; Memmos, D; Papagianni, A; Tsamelashvili, M	1
Buzyn, A; Combe, C; Delmas, Y; Fakhouri, F; Glowacki, F; Hummel, A; Knebelmann, B; Lesavre, P; Maillard, N; Noël, LH; Nusbaum, S; Patey-Mariaud de Serre, N; Presne, C; Radford, I; Terrier, B	1
Asaka, M; Wada, T; Yamaya, H; Yokoyama, H	1
Dafnis, E; Goumenos, DS; Katopodis, KP; Liakopoulos, V; Passadakis, P; Siamopoulos, KC; Stefanidis, I; Vardaki, E; Vargemezis, V; Vlachojannis, JG	1
Lai, KN	1
Deegens, JK; Wetzels, JF	1
Derkx, FH; Schalekamp, MA; Weimar, W; Zietse, R	1
Colon, S; Couchoud, C; Pouteil-Noble, C; Touraine, JL	1
Bernstein, K; Cattran, DC; Churchill, DN; Clark, WF; Greenwood, C; Lavoie, S; Morrin, PA; Ritchie, S	1
Keller, F; Krause, PH; Offermann, G; Schwarz, A	1
Meyrier, A	2
Brenchley, PE; Coupes, BM; Newstead, CG; Short, CD	1
Baumelou, A; Bletry, O; Deray, G; Faucher, C; Godeau, P; Jacobs, C; Rieu, P	1
Alaniz, C; Brosius, FC; Palmieri, J	1
Belghiti, D; Ben Maadi, A; Lagrue, G; Lang, P; Rémy, P; Rostoker, G; Weil, B	1
Rakowski, T; Rotellar, C; Winchester, JF	1
Mampaso, F; Marcen, R; Navarro-Antolin, J; Orofino, L; Ortuño, J; Rivera, ME; Teruel, JL	1
Ambalavanan, S; Fauvel, JP; Myers, BD; Sibley, RK	1
Diem, G; Eisterer, W; Hilbe, W; Ludescher, C; Neyer, U; Ohlschlegel, C; Thaler, J	1
Hashefi, M; Lal, SM; Luger, AM; Ross, G	1
Ponticelli, C; Villa, M	1
Appel, G; Klein, M; Radhakrishnan, J	1
Budde, K; Charissé, G; Färber, L; Fritsche, L; Gaedeke, J; Kunz, R; Neumayer, HH	1
Agliata, S; Airoldi, G; Cavagnino, A; Fortina, F; Ragazzoni, E; Sacco, A; Schweiger, K; Tommasini, G	1
Austin, HA; Balow, JE; Boumpas, DT; Fleisher, TA; Kim, Y; Piscitelli, S; Pucino, F; Tassiulas, IO; Vaughan, E	1
Grcevska, L; Polenakovik, MH	1
Dogukan, A; Oymak, O; Ozbakir, O; Taskapan, H; Utas, C	1
Alexopoulos, E; Papagianni, A	1
Anavi, BL; Dimitrakov, DJ; Kumchev, EP; Manev, EI; Nikolov, DG; Pandeva, SM; Tilkian, EE; Tzekov, VD; Tzvetkova, ZT	1
Appel, GB; Cattran, DC; Hebert, LA; Hoy, WE; Hunsicker, LG; Kunis, CL; Maxwell, DR; Pohl, MA	1
Buzio, C; Cardarelli, F; Olivetti, G; Rossi, L; Vampa, ML	1
Passerini, P; Ponticelli, C	1
Grabensee, B; Heering, P; Plum, J; Schneider, A	1
Chen, H; Hu, W; Li, L; Liu, Z; Tang, Z; Wang, Q; Yao, X; Yin, G	1
Daré, A; Flynn, HW; Franco, RF; Jorge, R; Scott, IU	1
Kramer, P; Schalekamp, MA; Weimar, W; Wenting, GJ; Zietse, R	1
Weimar, W; Zietse, R	1
Guasch, A; Hall, BM; Myers, BD; Newton, L; Suranyi, M	1
Ponticelli, C	1
Barbara, JA; Gillis, D; Ho, JO; Smith, PS; Thomas, AC; Woodroffe, AJ	1
al Nawab, M; Bass, PS; Davies, DR; Evans, B; Thomas, H; Wang, Y	1
Oe, PL; Pals, SL; van der Meulen, J; Zweegman, S	1
Pomrantz, A; Suthanthiran, M; Tejani, A	1

Reviews

29 review(s) available for cyclosporine and Glomerulonephritis, Membranous

Article	Year
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. The Cochrane database of systematic reviews, 2021, 11-15, Volume: 11 Topics: Azathioprine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephrotic Syndrome	2021
Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studies. Nephrologie & therapeutique, 2022, Volume: 18, Issue:2 Topics: Autoantibodies; Autoantigens; Cyclophosphamide; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Receptors, Phospholipase A2; Recurrence; Rituximab	2022
Strategies Towards Antigen-Specific Treatments for Membranous Nephropathy. Frontiers in immunology, 2022, Volume: 13 Topics: Animals; Autoantibodies; B-Lymphocytes; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Remission Induction; Rituximab	2022
Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis. International urology and nephrology, 2023, Volume: 55, Issue:3 Topics: Adult; Cyclophosphamide; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Network Meta-Analysis; Rituximab; Tacrolimus; Treatment Outcome	2023
Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis. Medicine, 2020, Volume: 99, Issue:16 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Immunological; Case-Control Studies; Chlorambucil; Cyclophosphamide; Cyclosporine; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Proteinuria; Randomized Controlled Trials as Topic; Receptors, Phospholipase A2; Remission Induction; Rituximab; Safety; Serum Albumin; Treatment Outcome	2020
Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis. PloS one, 2017, Volume: 12, Issue:9 Topics: Chlorambucil; Cyclophosphamide; Cyclosporine; Drug Tolerance; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Randomized Controlled Trials as Topic; Tacrolimus	2017
Efficacy and Safety of Tacrolimus versus Cyclosporine A for Idiopathic Membranous Nephropathy:A Network Meta-analysis. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2018, Feb-28, Volume: 40, Issue:1 Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Network Meta-Analysis; Tacrolimus	2018
Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis. International immunopharmacology, 2019, Volume: 70 Topics: China; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Infections; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Risk; Tacrolimus	2019
[Steroid and cyclosporine therapy in idiopathic membranous nephropathy: monocentric experience and literature review]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2019, Jun-11, Volume: 36, Issue:3 Topics: Adult; Aged; Cyclosporine; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Remission Induction; Retrospective Studies	2019
Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population. Drug design, development and therapy, 2019, Volume: 13 Topics: Asian People; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male	2019
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. The Cochrane database of systematic reviews, 2014, Oct-16, Issue:10 Topics: Adrenal Cortex Hormones; Adult; Alkylating Agents; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Nephrotic Syndrome; Proteinuria; Randomized Controlled Trials as Topic	2014
What have we learned from the use of ciclosporin A in the treatment of nephrotic patients with idiopathic membranous nephropathy? Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:10 Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Recurrence; Time Factors	2008
Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults. PloS one, 2012, Volume: 7, Issue:9 Topics: Adult; Alkylating Agents; Calcineurin Inhibitors; China; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Tacrolimus	2012
Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy. Seminars in nephrology, 2003, Volume: 23, Issue:3 Topics: Cyclosporine; Disease Progression; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Randomized Controlled Trials as Topic; Risk Factors	2003
[Membranous kidney diseases in adults]. Medicina, 2004, Volume: 64, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Chlorambucil; Cyclophosphamide; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Prognosis	2004
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. The Cochrane database of systematic reviews, 2004, Oct-18, Issue:4 Topics: Adult; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Randomized Controlled Trials as Topic	2004
Membranous nephropathy in the older adult: epidemiology, diagnosis and management. Drugs & aging, 2007, Volume: 24, Issue:9 Topics: Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Cytotoxins; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Nephrotic Syndrome; Palliative Care	2007
Use of cyclosporin in membranous and mesangioproliferative (IgA) nephropathy. Contributions to nephrology, 1995, Volume: 114 Topics: Cyclosporine; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents	1995
Pharmacologic management of adult idiopathic nephrotic syndrome. Clinical pharmacy, 1993, Volume: 12, Issue:6 Topics: Adrenal Cortex Hormones; Chlorambucil; Cyclosporine; Drug Therapy, Combination; Edema; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Proteinuria; Randomized Controlled Trials as Topic	1993
Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy. Nephron, 1993, Volume: 63, Issue:3 Topics: Adult; Aged; Cyclosporine; Drug Evaluation; Female; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Time Factors	1993
Cytotoxics, cyclosporine and membranous nephropathy. Current opinion in nephrology and hypertension, 1996, Volume: 5, Issue:5 Topics: Adrenal Cortex Hormones; Chlorambucil; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Probability; Randomized Controlled Trials as Topic; Remission Induction; Risk; Survival Rate	1996
Does cyclosporin have a role in the treatment of membranous nephropathy? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:1 Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents	1999
Cyclosporine treatment of glomerular diseases. Annual review of medicine, 1999, Volume: 50 Topics: Autoimmune Diseases; Azathioprine; Cyclosporine; Drug Combinations; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Nephrotic Syndrome; Recurrence; Steroids	1999
Treatment of idiopathic membranous nephropathy (IMN). Renal failure, 2000, Volume: 22, Issue:6 Topics: Antineoplastic Agents, Alkylating; Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Nephrotic Syndrome	2000
Membranous glomerulonephritis after haematopoietic cell transplantation for multiple myeloma. Nephron, 2001, Volume: 88, Issue:3 Topics: Cyclosporine; Glomerulonephritis, Membranous; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; Nephrotic Syndrome	2001
Treatment of membranous nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16 Suppl 5 Topics: Adrenal Cortex Hormones; Chlorambucil; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents	2001
Antiproteinuric and immunological effects of cyclosporin A in the treatment of glomerular diseases. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1992, Volume: 7 Suppl 1 Topics: Cyclosporine; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Humans; Immune System; Kidney Diseases; Lupus Nephritis; Nephrotic Syndrome; Proteinuria	1992
[Indications for cyclosporin in the treatment of idiopathic nephrotic syndrome in adults]. Nederlands tijdschrift voor geneeskunde, 1992, Sep-05, Volume: 136, Issue:36 Topics: Cyclosporine; Drug Administration Schedule; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Nephrosis, Lipoid; Nephrotic Syndrome	1992
Treatment of the nephrotic syndrome with cyclosporin A. Journal of autoimmunity, 1992, Volume: 5 Suppl A Topics: Chlorambucil; Cyclophosphamide; Cyclosporine; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Methylprednisolone; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone	1992

Trials

20 trial(s) available for cyclosporine and Glomerulonephritis, Membranous

Article	Year
The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial. Journal of Korean medical science, 2018, Feb-26, Volume: 33, Issue:9 Topics: Adrenal Cortex Hormones; Adult; Aged; Antibiotics, Antineoplastic; Antibodies; Cyclosporine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Quality of Life; Receptors, Phospholipase A2; Remission Induction; Treatment Outcome	2018
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy. The New England journal of medicine, 2019, 07-04, Volume: 381, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cyclosporine; Drug Administration Schedule; Female; Glomerulonephritis, Membranous; Humans; Immunologic Factors; Immunosuppressive Agents; Infusions, Intravenous; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Proteinuria; Remission Induction; Rituximab; Treatment Failure; Young Adult	2019
Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial. Clinical and experimental nephrology, 2014, Volume: 18, Issue:5 Topics: Adolescent; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Prednisolone; Prospective Studies; Young Adult	2014
Patient age and the prognosis of idiopathic membranous nephropathy. PloS one, 2014, Volume: 9, Issue:10 Topics: Age Factors; Aged; Aging; Anti-Inflammatory Agents; Cyclosporine; Follow-Up Studies; Glomerulonephritis, Membranous; Hospitalization; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Prednisolone; Prognosis; Proteinuria; Urinary Tract Infections	2014
Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy. Genetics and molecular research : GMR, 2015, Mar-30, Volume: 14, Issue:1 Topics: Aged; Aged, 80 and over; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Prospective Studies; Proteinuria; Treatment Outcome; Urinary Tract Infections	2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR). Nephron, 2015, Volume: 130, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; B-Lymphocytes; Blood Pressure; Cyclosporine; Endpoint Determination; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Patient Safety; Proteinuria; Rituximab; Treatment Outcome; Young Adult	2015
Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy. Renal failure, 2010, Volume: 32, Issue:5 Topics: Cyclophosphamide; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Lisinopril; Male; Middle Aged; Nephrotic Syndrome; Prospective Studies	2010
Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2011, Volume: 65, Issue:2 Topics: Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Nephrotic Syndrome; Prospective Studies; Proteinuria; Recurrence; Risk Factors; Treatment Outcome	2011
Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy. Nephrology (Carlton, Vic.), 2010, Volume: 15, Issue:8 Topics: Adult; Aged; Cost-Benefit Analysis; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Prednisolone; Recurrence; Remission Induction; Treatment Outcome	2010
Outcome of idiopathic membranous nephropathy using targeted stepwise immunosuppressive treatment strategy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:9 Topics: Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Mycophenolic Acid; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome	2011
Efficacy and safety of rituximab second-line therapy for membranous nephropathy: a prospective, matched-cohort study. American journal of nephrology, 2011, Volume: 33, Issue:5 Topics: Adult; Alkylating Agents; Antibodies, Monoclonal, Murine-Derived; Biopsy; Cohort Studies; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Immunologic Factors; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Proteinuria; Remission Induction; Rituximab	2011
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial. Lancet (London, England), 2013, Mar-02, Volume: 381, Issue:9868 Topics: Chlorambucil; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney; Middle Aged; Prednisolone; Survival Analysis; United Kingdom	2013
Clinical correlates of serial urinary membrane attack complex estimates in patients with idiopathic membranous nephropathy. Clinical nephrology, 2003, Volume: 60, Issue:1 Topics: Adult; Aged; Complement Membrane Attack Complex; Cyclosporine; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Middle Aged	2003
The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy. Clinical nephrology, 2004, Volume: 61, Issue:1 Topics: Biopsy; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Male; Middle Aged; Nephrotic Syndrome; Prednisolone; Recurrence; Remission Induction	2004
Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:11 Topics: Cyclosporine; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Long-Term Care; Male; Middle Aged; Nephrotic Syndrome; Prednisolone; Recurrence; Treatment Outcome	2006
A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney international, 1995, Volume: 47, Issue:4 Topics: Adult; Aged; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Prospective Studies; Proteinuria; Risk Factors; Urea	1995
Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy. Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:2 Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Cyclosporine; Enalapril; Female; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Proteinuria; Time Factors	1996
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney international, 2001, Volume: 59, Issue:4 Topics: Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Prospective Studies; Proteinuria; Recurrence; Retreatment; Single-Blind Method; Steroids; Treatment Outcome	2001
Cyclosporin A treatment for idiopathic membranous nephropathy. Chinese medical journal, 2001, Volume: 114, Issue:12 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Remission Induction; Treatment Outcome	2001
A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children. Nephron, 1991, Volume: 59, Issue:1 Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Infant; Interleukin-2; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; T-Lymphocyte Subsets	1991

Other Studies

93 other study(ies) available for cyclosporine and Glomerulonephritis, Membranous

Article	Year
Cyclosporine A-Induced Conchal Hyperplasia with Nasal Obstruction in a Patient with Membranous Nephropathy. The American journal of case reports, 2022, May-21, Volume: 23 Topics: Aged; Cyclosporine; Female; Gingival Hyperplasia; Glomerulonephritis, Membranous; Hirsutism; Humans; Hyperplasia; Immunosuppressive Agents; Nasal Obstruction; Proteinuria; Turbinates	2022
[A novel approach to rapid induction of remission in primary membranous nephropathy]. Terapevticheskii arkhiv, 2021, Jun-15, Volume: 93, Issue:6 Topics: Angiotensins; Cyclophosphamide; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prospective Studies; Receptors, Phospholipase A2; Remission Induction; Renin; Rituximab; Treatment Outcome	2021
An 8-month-old boy with infantile nephrotic syndrome caused by semaphorin 3B-associated membranous nephropathy. CEN case reports, 2023, Volume: 12, Issue:3 Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Infant; Male; Nephrotic Syndrome; Prednisolone; Semaphorins	2023
Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists. Clinical and experimental nephrology, 2023, Volume: 27, Issue:9 Topics: Adrenal Cortex Hormones; Adult; Cross-Sectional Studies; Cyclosporine; East Asian People; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Guideline Adherence; Humans; Internet; Nephrologists; Nephrosis, Lipoid; Nephrotic Syndrome; Practice Patterns, Physicians'; Surveys and Questionnaires	2023
[Pharmacogenetic testing improves treatment responses in patients with PLA2R-related membranous nephropathy]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2023, Jun-20, Volume: 43, Issue:6 Topics: Autoantibodies; Cyclosporine; Glomerulonephritis, Membranous; Homozygote; Humans; Immunosuppressive Agents; Pharmacogenomic Testing; Receptors, Phospholipase A2; Sequence Deletion; Serum Albumin; Tacrolimus	2023
A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance. Pediatric nephrology (Berlin, Germany), 2024, Volume: 39, Issue:1 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Child, Preschool; Cyclosporine; Glomerulonephritis, Membranous; Humans; Male; Nephrotic Syndrome; Proteinuria; Rituximab; Semaphorins	2024
Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy. Clinical journal of the American Society of Nephrology : CJASN, 2023, 10-01, Volume: 18, Issue:10 Topics: Albumins; Autoantibodies; Creatinine; Cyclosporine; Glomerulonephritis, Membranous; Humans; Receptors, Phospholipase A2; Risk Factors; Rituximab	2023
IgG4-Related Membranous Nephropathy with Acute Nephrotic Syndrome During Successful Steroid Maintenance Treatment for Type 1 Autoimmune Pancreatitis. The American journal of case reports, 2023, Aug-18, Volume: 24 Topics: Acute Disease; Autoimmune Pancreatitis; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunoglobulin G4-Related Disease; Insulin; Male; Methylprednisolone; Nephrotic Syndrome; Proteinuria; Steroids	2023
Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy. The Korean journal of internal medicine, 2019, Volume: 34, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Communicable Diseases; Cyclosporine; Disease Progression; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Remission Induction; Renal Replacement Therapy; Retrospective Studies; Risk Assessment; Risk Factors; Seoul; Time Factors; Treatment Outcome	2019
MENTOR heralds a new era of therapy for membranous nephropathy. Nature reviews. Nephrology, 2019, Volume: 15, Issue:11 Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Rituximab	2019
Rituximab or Cyclosporine for Membranous Nephropathy. The New England journal of medicine, 2019, 10-24, Volume: 381, Issue:17 Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Rituximab	2019
Rituximab or Cyclosporine for Membranous Nephropathy. The New England journal of medicine, 2019, 10-24, Volume: 381, Issue:17 Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Rituximab	2019
Rituximab or Cyclosporine for Membranous Nephropathy. Reply. The New England journal of medicine, 2019, 10-24, Volume: 381, Issue:17 Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Rituximab	2019
Management of Membranous Nephropathy after MENTOR. Clinical journal of the American Society of Nephrology : CJASN, 2020, 03-06, Volume: 15, Issue:3 Topics: Clinical Decision-Making; Clinical Trials as Topic; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Remission Induction; Research Design; Rituximab; Treatment Outcome	2020
Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study. Nephrology (Carlton, Vic.), 2020, Volume: 25, Issue:3 Topics: Adult; Cyclophosphamide; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Kidney; Male; Middle Aged; Prognosis; Receptors, Phospholipase A2; Retrospective Studies	2020
The evolution of the therapeutic approach to membranous nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2021, 04-26, Volume: 36, Issue:5 Topics: Adult; Antibodies; Antineoplastic Agents; Cyclosporine; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Proteinuria; Receptors, Phospholipase A2; Rituximab; Treatment Outcome	2021
Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression. PloS one, 2021, Volume: 16, Issue:8 Topics: Adult; Cyclosporine; Female; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus; Treatment Outcome	2021
Long-term Low-density Lipoprotein Apheresis in a Patient with Refractory Idiopathic Membranous Glomerulonephritis. Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:12 Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Lipoproteins, LDL; Male; Middle Aged; Nephrotic Syndrome; Proteinuria	2017
Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience. Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:13 Topics: Adrenal Cortex Hormones; Adult; Aged; Asian People; Cyclophosphamide; Cyclosporine; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Ribonucleosides; Rituximab	2017
Low-dose cyclosporine in treatment of membranous nephropathy with nephrotic syndrome: effectiveness and renal safety. Renal failure, 2017, Volume: 39, Issue:1 Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Kidney Function Tests; Male; Middle Aged; Nephrotic Syndrome; Prednisolone; Prospective Studies; Treatment Outcome	2017
A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis. Internal medicine (Tokyo, Japan), 2018, Oct-01, Volume: 57, Issue:19 Topics: Anti-Inflammatory Agents; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Male; Middle Aged; Nephritis, Interstitial; Nephrotic Syndrome; Pancreatitis; Prednisolone; Proteinuria	2018
Analysis of predictive factors for immunosuppressive response in anti-phospholipase A2 receptor antibody positive membranous nephropathy. BMC nephrology, 2018, 12-12, Volume: 19, Issue:1 Topics: Adult; Area Under Curve; Autoantibodies; Cyclophosphamide; Cyclosporine; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Proteinuria; Receptors, Phospholipase A2; Retrospective Studies; ROC Curve	2018
A case report of cyclosporine-induced myopathy with subacute muscular atrophy as initial presentation. Medicine, 2019, Volume: 98, Issue:16 Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Muscular Atrophy; Muscular Diseases	2019
A First Step toward a New Approach to Treating Membranous Nephropathy. The New England journal of medicine, 2019, 07-04, Volume: 381, Issue:1 Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Receptors, Phospholipase A2; Rituximab	2019
ACP Journal Club. Prednisolone plus chlorambucil preserved renal function in membranous nephropathy. Annals of internal medicine, 2013, May-21, Volume: 158, Issue:10 Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prednisolone	2013
Stepwise treatment using corticosteroids alone and in combination with cyclosporine in korean patients with idiopathic membranous nephropathy. Yonsei medical journal, 2013, Volume: 54, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Drug Administration Schedule; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney; Male; Middle Aged; Proteinuria; Treatment Outcome	2013
Immunosuppression for membranous nephropathy. Lancet (London, England), 2013, Jun-22, Volume: 381, Issue:9884 Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prednisolone	2013
Immunosuppression for membranous nephropathy. Lancet (London, England), 2013, Jun-22, Volume: 381, Issue:9884 Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prednisolone	2013
Immunosuppression for membranous nephropathy. Lancet (London, England), 2013, Jun-22, Volume: 381, Issue:9884 Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prednisolone	2013
Immunosuppression for membranous nephropathy. Lancet (London, England), 2013, Jun-22, Volume: 381, Issue:9884 Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prednisolone	2013
Immunosuppression for membranous nephropathy. Lancet (London, England), 2013, Jun-22, Volume: 381, Issue:9884 Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prednisolone	2013
Immunosuppression for membranous nephropathy - Authors' reply. Lancet (London, England), 2013, Jun-22, Volume: 381, Issue:9884 Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prednisolone	2013
Tonsillar Kaposi sarcoma in a patient with membranous glomerulonephritis on immunosuppressive therapy. Ear, nose, & throat journal, 2013, Volume: 92, Issue:7 Topics: Adult; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Prednisolone; Sarcoma, Kaposi; Tonsillar Neoplasms	2013
[Complete remission of repeated recurrent membranous nephropathy after non-myeloablative allogeneic peripheral blood stem cell transplantation]. Nihon Jinzo Gakkai shi, 2013, Volume: 55, Issue:7 Topics: Allografts; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Treatment Outcome	2013
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR). Clinical and experimental nephrology, 2015, Volume: 19, Issue:3 Topics: Aged; Aged, 80 and over; Biopsy; Creatinine; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Male; Methylprednisolone; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Registries; Retrospective Studies; Ribonucleosides; Treatment Outcome	2015
M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. Clinical journal of the American Society of Nephrology : CJASN, 2014, Nov-07, Volume: 9, Issue:11 Topics: Adult; Age Factors; Aged; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Creatinine; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Proteins; Proteinuria; Receptors, Phospholipase A2; Rituximab; Sex Factors	2014
Improving long-term outcomes in idiopathic membranous nephropathy using a distinctive cyclosporine regimen. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2016, Volume: 68, Issue:3 Topics: Adult; Aged; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome	2016
A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis. European journal of clinical investigation, 2015, Volume: 45, Issue:12 Topics: Administration, Oral; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Plasma Exchange; Prednisolone; Recurrence; Remission Induction; Retrospective Studies; Rituximab	2015
[The clinical efficacy and safety of modified Ponticelli regimen for treatment of idiopathic membranous nephropathy]. Zhonghua nei ke za zhi, 2016, Volume: 55, Issue:3 Topics: Clinical Protocols; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Lipids; Liver; Proteinuria; Remission Induction; Retrospective Studies; Treatment Outcome	2016
Endoplasmic Reticulum Stress Predicts Clinical Response to Cyclosporine Treatment in Primary Membranous Nephropathy. American journal of nephrology, 2016, Volume: 43, Issue:5 Topics: Adult; Aged; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Female; Glomerulonephritis, Membranous; Heat-Shock Proteins; Humans; Kidney; Male; Middle Aged; Retrospective Studies	2016
Idiosyncratic drug reactions and membranous glomerulopathy. BMJ case reports, 2017, Jan-30, Volume: 2017 Topics: Cell Survival; Cyclosporine; Deprescriptions; Drug Substitution; Enteritis; Eosinophilia; Failure to Thrive; Gastritis; Gingival Hyperplasia; Glomerulonephritis, Membranous; Humans; Hypertrichosis; Immunosuppressive Agents; In Vitro Techniques; Infant; Kidney Glomerulus; Male; Microscopy, Electron; Muscle Weakness; Seizures; Serositis; Tacrolimus; Vasculitis	2017
Early initiation of immunosuppressive treatment in membranous nephropathy patients. Journal of the Formosan Medical Association = Taiwan yi zhi, 2017, Volume: 116, Issue:4 Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Proteinuria; Regression Analysis; Remission Induction; Retrospective Studies; Steroids; Taiwan	2017
Hemolytic uremic syndrome with ischemic glomerulonephropathy and obliterative vasculopathy in a systemic sclerosis patient treated with cyclosporine-A. Rheumatology international, 2009, Volume: 29, Issue:7 Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic; Antirheumatic Agents; Asian People; Creatinine; Cyclosporine; Glomerulonephritis, Membranous; Hemolytic-Uremic Syndrome; Humans; Ischemia; Kidney; Male; Plasma Exchange; Renal Artery; Scleroderma, Systemic; Steroids; Taiwan; Thrombocytopenia; Vasculitis	2009
An unusual case of loin pain and nephritis. Clinical and experimental nephrology, 2010, Volume: 14, Issue:1 Topics: Adolescent; Cyclosporine; DNA; Enoxaparin; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Low Back Pain; Lupus Erythematosus, Systemic; Nephrotic Syndrome; Prednisolone; Proteinuria; Renal Veins; Venous Thrombosis	2010
Idiopathic membranous nephropathy associated with polycystic kidney disease. Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:5 Topics: Biopsy; Child; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Hematuria; Humans; Immunosuppressive Agents; Kidney; Male; Nephrotic Syndrome; Polycystic Kidney Diseases; Prednisone; Renal Insufficiency; Severity of Illness Index; Treatment Outcome	2010
Low-dose cyclosporine treatment in Chinese nephrotic patients with idiopathic membranous nephropathy: An uncontrolled study with prospective follow-up. The American journal of the medical sciences, 2010, Volume: 339, Issue:6 Topics: Adolescent; Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Prospective Studies; Young Adult	2010
[Acute inflammatory polyradiculoneuropathy and membranous glomerulonephritis following Epbstein-Barr virus primary infection in a 12-year-old girl]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2010, Volume: 17, Issue:11 Topics: Ataxia; Child; Cyclosporine; Drug Therapy, Combination; Epstein-Barr Virus Infections; Facial Paralysis; Female; Glomerulonephritis, Membranous; Glucocorticoids; Guillain-Barre Syndrome; Herpesvirus 4, Human; Humans; Immunoglobulins; Immunologic Factors; Immunosuppressive Agents; Intracranial Hypertension; Treatment Outcome	2010
A case of membranous nephropathy with primary biliary cirrhosis and cyclosporine-induced remission. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:3 Topics: Aged; Biopsy; Comorbidity; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney; Liver; Liver Cirrhosis, Biliary; Male; Proteinuria; Remission Induction; Treatment Outcome	2011
Identification of novel indicators of cyclosporine A nephrotoxicity in a CD-1 mouse model. Toxicology and applied pharmacology, 2011, Apr-15, Volume: 252, Issue:2 Topics: Animals; Cyclosporine; Disease Models, Animal; Glomerulonephritis; Glomerulonephritis, Membranous; Kidney; Male; Mice; Nephritis	2011
Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:18 Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Biopsy; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Incidence; Japan; Kidney; Male; Middle Aged; Prednisolone; Prospective Studies; Recurrence; Retrospective Studies; Treatment Outcome	2011
Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years. Chinese medical journal, 2011, Volume: 124, Issue:21 Topics: Adult; Aged; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Retrospective Studies; Treatment Outcome	2011
Membranous nephropathy with renal salt wasting: role of neurohumoral factors in sodium retention. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2012, Volume: 60, Issue:3 Topics: Blood Chemical Analysis; Creatinine; Cyclosporine; Disease Progression; Drug Therapy, Combination; Edema; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Hypernatremia; Kidney Function Tests; Middle Aged; Nephrotic Syndrome; Neurotransmitter Agents; Prednisone; Risk Assessment; Severity of Illness Index; Treatment Outcome	2012
Membranous nephropathy induced by pegylated interferon alpha-2a therapy for chronic viral hepatitis B. Clinical nephrology, 2012, Volume: 77, Issue:6 Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Biopsy; Cyclosporine; Drug Substitution; Glomerulonephritis, Membranous; Guanine; Hepatitis B, Chronic; Humans; Immunohistochemistry; Immunosuppressive Agents; Interferon-alpha; Kidney; Male; Nephrotic Syndrome; Polyethylene Glycols; Recombinant Proteins; Treatment Outcome	2012
Combined administration of low-dose prednisolone and cyclosporine in idiopathic membranous nephropathy: Tsukuba's regimen for IMN. Clinical and experimental nephrology, 2012, Volume: 16, Issue:4 Topics: Anti-Inflammatory Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Japan; Prednisolone; Retrospective Studies; Treatment Outcome	2012
Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy. Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:18 Topics: Adult; Aged; Blood Component Removal; Cyclosporine; Drug Resistance; Female; Glomerulonephritis, Membranous; Humans; Lipoproteins, LDL; Male; Recurrence; Steroids; Treatment Outcome; Water-Electrolyte Balance	2012
Does treatment with corticosteroids and cyclosporine reduce transglutaminase type 2 expression in the renal tissue of patients with membranous nephropathy? Nephron. Clinical practice, 2012, Volume: 121, Issue:1-2 Topics: Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Case-Control Studies; Creatinine; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Fibrosis; Follow-Up Studies; Glomerulonephritis, Membranous; GTP-Binding Proteins; Humans; Immunosuppressive Agents; Linear Models; Male; Middle Aged; Prednisolone; Protein Glutamine gamma Glutamyltransferase 2; Statistics, Nonparametric; Transglutaminases; Treatment Outcome	2012
Membranous nephropathy in a 13-year-old boy with common variable immunodeficiency. Journal of Korean medical science, 2012, Volume: 27, Issue:11 Topics: Adolescent; Bronchiectasis; Common Variable Immunodeficiency; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Immunoglobulins; Immunosuppressive Agents; Injections, Intravenous; Kidney; Male; Pneumonia; Proteinuria; Steroids	2012
Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy. Kidney international, 2013, Volume: 83, Issue:3 Topics: Adaptor Proteins, Signal Transducing; Adult; Apoptosis Regulatory Proteins; Calcium-Calmodulin-Dependent Protein Kinases; Carrier Proteins; Cyclosporine; Death-Associated Protein Kinases; Glomerulonephritis, Membranous; Humans; Podocytes; Protein Serine-Threonine Kinases; Up-Regulation	2013
Idiopathic membranous nephropathy: back to the future? Lancet (London, England), 2013, Mar-02, Volume: 381, Issue:9868 Topics: Chlorambucil; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prednisolone	2013
Effects of carvedilol and BL-443 on kidney of rats with cyclosporine nephropathy. General physiology and biophysics, 2002, Volume: 21, Issue:2 Topics: Animals; Carbamates; Carbazoles; Carvedilol; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Isoenzymes; Kidney; L-Lactate Dehydrogenase; L-Lactate Dehydrogenase (Cytochrome); Male; Propanolamines; Rats; Rats, Wistar; Reference Values	2002
[Quadritherapy with cyclosporine for membranous lupus nephropathy]. Nihon Jinzo Gakkai shi, 2003, Volume: 45, Issue:7 Topics: Adult; Angiotensin Receptor Antagonists; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug; Remission Induction; Tetrazoles; Treatment Outcome; Valine; Valsartan	2003
Cyclosporine A in treatment of membranous lupus nephropathy. Chinese medical journal, 2003, Volume: 116, Issue:12 Topics: Adolescent; Adult; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Lupus Nephritis; Male; Prednisone; Retrospective Studies; Treatment Outcome	2003
[Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2004, Volume: 24 Suppl 3 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcineurin Inhibitors; Calcium Channel Blockers; Creatinine; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Hypercholesterolemia; Hypertension; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Diseases; Lisinopril; Lovastatin; Male; Nephrotic Syndrome; Prednisone; Recurrence; Verapamil	2004
Cyclosporin A-induced remission of primary membranous glomerulonephritis in a child. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:12 Topics: Child, Preschool; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Prednisolone	2004
Nephrotic syndrome after stem cell transplantation. Clinical transplantation, 2005, Volume: 19, Issue:1 Topics: Adult; Cyclosporine; Fatal Outcome; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Stem Cell Transplantation; Treatment Outcome	2005
The CARI guidelines. Prevention of progression of kidney disease. Nephrology (Carlton, Vic.), 2006, Volume: 11 Suppl 1 Topics: Acidosis; Adult; Analgesics; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Child; Cyclosporine; Diabetic Nephropathies; Diet, Protein-Restricted; Exercise; Female; Fish Oils; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hyperuricemia; Kidney Diseases; Kidney Failure, Chronic; Phosphates; Pregnancy; Pregnancy Complications; Proteinuria; Renal Artery Obstruction; Smoking Cessation; Tonsillectomy	2006
Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:5 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Biopsy; Chronic Disease; Cyclosporine; Female; Glomerulonephritis, Membranous; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney; Male; Middle Aged; Treatment Outcome	2007
[Advances in the treatment of adult nephrotic syndrome]. Nihon Jinzo Gakkai shi, 2007, Volume: 49, Issue:2 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Rituximab; Tacrolimus	2007
Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. American journal of nephrology, 2007, Volume: 27, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Cytotoxins; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Nephrotic Syndrome; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome	2007
Membranous nephropathy: when and how to treat. Kidney international, 2007, Volume: 71, Issue:9 Topics: Adrenal Cortex Hormones; Angiotensin-Converting Enzyme Inhibitors; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Function Tests; Nephrotic Syndrome; Tacrolimus	2007
Cyclosporin and the glomerular filtration barrier in minimal change disease and membranous glomerulopathy. Contributions to nephrology, 1995, Volume: 114 Topics: Cyclosporine; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Hemodynamics; Humans; Immunosuppressive Agents; Proteinuria; Remission Induction	1995
Recurrence of membranous nephropathy after renal transplantation. Incidence and risk factors in 1614 patients. Transplantation, 1995, May-15, Volume: 59, Issue:9 Topics: Adult; Aged; Cyclosporine; Glomerulonephritis, Membranous; Graft Rejection; HLA-DR3 Antigen; Humans; Kidney Transplantation; Middle Aged; Recurrence; Risk Factors; Survival Analysis	1995
Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation. Transplantation, 1994, Sep-27, Volume: 58, Issue:6 Topics: Adult; Cyclosporine; Female; Glomerulonephritis, Membranous; Graft Rejection; Graft Survival; Humans; Incidence; Kidney Transplantation; Male; Nephrotic Syndrome; Prevalence; Retrospective Studies; Transplantation, Homologous	1994
Treatment of nephrotic syndrome with cyclosporin A. What remains in 1994? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1994, Volume: 9, Issue:6 Topics: Cyclosporine; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Nephrotic Syndrome	1994
Transforming growth factor beta 1 in renal allograft recipients. Transplantation, 1994, Jun-27, Volume: 57, Issue:12 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Creatinine; Cyclosporine; Female; Glomerulonephritis, Membranous; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Reference Values; Regression Analysis; Transforming Growth Factor beta; Transplantation, Homologous	1994
Medical nephrectomy with CsA and angiotensin II in a case of life-threatening membranous glomerulonephritis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1994, Volume: 9, Issue:1 Topics: Adult; Angiotensin II; Cyclosporine; Glomerulonephritis, Membranous; Humans; Kidney; Male; Nephrectomy; Nephrotic Syndrome	1994
Short-term responsiveness of membranous glomerulopathy to cyclosporine. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1993, Volume: 21, Issue:5 Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Levamisole; Time Factors	1993
Membranous nephropathy: recurrence after kidney transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:6 Topics: Adult; Cyclosporine; Fluorescent Antibody Technique; Glomerulonephritis, Membranous; Humans; Kidney; Kidney Transplantation; Male; Microscopy, Electron; Middle Aged; Postoperative Care; Postoperative Complications; Prednisone; Proteinuria; Recurrence; Renal Dialysis	1996
Effect of cyclosporin A in a patient with refractory nephrotic syndrome associated with B chronic lymphocytic leukemia. Nephron, 1996, Volume: 72, Issue:3 Topics: Biopsy; Cyclosporine; Dose-Response Relationship, Drug; Female; Glomerulonephritis, Membranous; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Nephrotic Syndrome	1996
De novo membranous glomerulopathy in a renal transplant patient treated with FK 506. The first reported case. The International journal of artificial organs, 1997, Volume: 20, Issue:7 Topics: Basement Membrane; Cyclosporine; Diabetic Nephropathies; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Male; Microscopy, Fluorescence; Middle Aged; Tacrolimus; Treatment Outcome	1997
Treatment of membranous glomerulopathy with cyclosporin A: how much patience is required? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:4 Topics: Adult; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Treatment Outcome	1999
[Nephrotic syndrome refractory to conventional therapy]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1999, Volume: 51, Issue:2 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Capillary Permeability; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney Glomerulus; Lupus Erythematosus, Systemic; Lymphokines; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; Treatment Outcome	1999
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy. Clinical nephrology, 1999, Volume: 52, Issue:2 Topics: Adult; Alkylating Agents; Anti-Inflammatory Agents; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Immunologic Memory; Immunosuppressive Agents; Lupus Nephritis; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Pilot Projects; Prednisone; Proteinuria; Renal Plasma Flow, Effective; Sinusitis; Vidarabine	1999
Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1999, Volume: 34, Issue:5 Topics: Adult; Chlorambucil; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Kidney Function Tests; Kidney Glomerulus; Male; Methylprednisolone; Middle Aged; Prednisolone; Treatment Outcome	1999
Transformation of hepatitis B virus-related membranous glomerulonephritis to crescentic form. Clinical nephrology, 2000, Volume: 54, Issue:2 Topics: Adult; Cyclosporine; Glomerulonephritis; Glomerulonephritis, Membranous; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Kidney Glomerulus; Male; Prednisolone; Virus Replication	2000
Cyclosporin A in the treatment of patients with nephrotic syndrome. Folia medica, 2000, Volume: 42, Issue:2 Topics: Adult; Amyloidosis; Cyclosporine; Female; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome	2000
[Effect of cyclosporin A on renal function in patients with glomerulonephritis]. Deutsche medizinische Wochenschrift (1946), 2001, Oct-05, Volume: 126, Issue:40 Topics: Adult; Blood Pressure; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Kidney Function Tests; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Prospective Studies	2001
Hemiretinal vein occlusion associated with membranous glomerulonephritis. American journal of ophthalmology, 2002, Volume: 133, Issue:3 Topics: Adult; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Fundus Oculi; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Prednisone; Retinal Vein Occlusion; Visual Acuity	2002
Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clinical science (London, England : 1979), 1992, Volume: 82, Issue:6 Topics: Adult; Aged; Basement Membrane; Cell Membrane Permeability; Cyclosporine; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Kidney Glomerulus; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Proteinuria	1992
Short-term responsiveness of membranous glomerulopathy to cyclosporine. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1992, Volume: 20, Issue:5 Topics: Adult; Aged; Cyclosporine; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Hypertension; Interferon-alpha; Interleukin-1; Interleukin-2; Leukocyte Count; Lymphocyte Activation; Male; Middle Aged; Nephrosis, Lipoid; Proteinuria; Recurrence; Remission Induction; T-Lymphocyte Subsets; Treatment Outcome; Tumor Necrosis Factor-alpha	1992
Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient. Clinical nephrology, 1992, Volume: 37, Issue:3 Topics: Adult; Antibodies, Antinuclear; Biopsy; Bone Marrow Transplantation; Cyclosporine; Fluorescent Antibody Technique; Glomerulonephritis, Membranous; Graft vs Host Disease; Humans; Kidney; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Prednisolone	1992
The effect of cyclosporin A on cationized bovine serum albumin-induced nephropathy in NZW rabbits. The Journal of pathology, 1992, Volume: 167, Issue:1 Topics: Animals; Cations; Cyclosporine; Disease Models, Animal; Endotoxins; Escherichia coli; Glomerulonephritis, Membranous; Immunosuppression Therapy; Kidney Glomerulus; Male; Rabbits; Serum Albumin, Bovine	1992
Progression of membranous glomerulopathy during cyclosporin A. Clinical nephrology, 1992, Volume: 37, Issue:6 Topics: Adult; Creatinine; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Male; Proteinuria	1992